Strs Ohio Has $65.26 Million Stock Position in Ventas, Inc. $VTR

Posted by Brenda Bartman on Jul 3rd, 2026

Strs Ohio boosted its position in Ventas, Inc. (NYSE:VTR – Free Report) by 22.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 797,951 shares of the real estate investment trust’s stock after acquiring an additional 145,783 shares during the period. Strs Ohio’s holdings in Ventas were worth $65,256,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Keybank National Association OH increased its holdings in shares of Ventas by 36.3% during the first quarter. Keybank National Association OH now owns 9,840 shares of the real estate investment trust’s stock valued at $805,000 after acquiring an additional 2,622 shares in the last quarter. Root Financial Partners LLC lifted its holdings in shares of Ventas by 751.1% in the 1st quarter. Root Financial Partners LLC now owns 1,200 shares of the real estate investment trust’s stock worth $98,000 after purchasing an additional 1,059 shares in the last quarter. Stock Yards Bank & Trust Co. lifted its holdings in shares of Ventas by 3.8% in the 1st quarter. Stock Yards Bank & Trust Co. now owns 12,105 shares of the real estate investment trust’s stock worth $990,000 after purchasing an additional 439 shares in the last quarter. USS Investment Management Ltd grew its position in Ventas by 3.2% in the 1st quarter. USS Investment Management Ltd now owns 106,727 shares of the real estate investment trust’s stock valued at $8,727,000 after purchasing an additional 3,336 shares during the period. Finally, IFM Investors Pty Ltd grew its position in Ventas by 2.7% in the 1st quarter. IFM Investors Pty Ltd now owns 168,520 shares of the real estate investment trust’s stock valued at $13,782,000 after purchasing an additional 4,387 shares during the period. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Price Performance

Shares of NYSE:VTR opened at $92.57 on Friday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The stock has a market cap of $45.00 billion, a PE ratio of 168.31, a price-to-earnings-growth ratio of 1.93 and a beta of 0.70. The stock’s fifty day simple moving average is $85.67 and its two-hundred day simple moving average is $83.13. Ventas, Inc. has a 1-year low of $62.06 and a 1-year high of $92.86.

Ventas (NYSE:VTR – Get Free Report) last posted its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business’s revenue was up 22.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, analysts forecast that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s dividend payout ratio is presently 378.18%.

Analyst Upgrades and Downgrades

VTR has been the topic of several research reports. UBS Group upped their price objective on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a report on Monday, May 4th. Evercore reiterated an “outperform” rating and set a $95.00 price objective on shares of Ventas in a report on Wednesday, April 29th. BMO Capital Markets reissued an “outperform” rating and set a $100.00 target price on shares of Ventas in a research report on Monday, May 4th. Raymond James Financial started coverage on shares of Ventas in a report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 target price on the stock. Finally, JPMorgan Chase & Co. raised their price target on shares of Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a research report on Monday, May 11th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Ventas presently has an average rating of “Moderate Buy” and a consensus price target of $96.00.

Check Out Our Latest Analysis on Ventas

Insider Transactions at Ventas

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.53% of the company’s stock.

Ventas Company Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.